Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

BridgeBio Pharma (BBIO) Shares Issued: 2019-2025

Historic Shares Issued for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to $4.8 million.

  • BridgeBio Pharma's Shares Issued rose 27005.56% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$262.1 million, marking a year-over-year decrease of 271.68%. This contributed to the annual value of $38.1 million for FY2024, which is 41.38% down from last year.
  • Latest data reveals that BridgeBio Pharma reported Shares Issued of $4.8 million as of Q3 2025, which was down 24.83% from $6.4 million recorded in Q2 2025.
  • Over the past 5 years, BridgeBio Pharma's Shares Issued peaked at $306.2 million during Q3 2023, and registered a low of -$385.3 million during Q4 2023.
  • For the 3-year period, BridgeBio Pharma's Shares Issued averaged around $10.7 million, with its median value being $4.8 million (2025).
  • As far as peak fluctuations go, BridgeBio Pharma's Shares Issued tumbled by 7,962.53% in 2023, and later surged by 27,005.56% in 2025.
  • BridgeBio Pharma's Shares Issued (Quarterly) stood at $2.3 million in 2021, then skyrocketed by 108.60% to $4.9 million in 2022, then slumped by 7,962.53% to -$385.3 million in 2023, then rose by 28.19% to -$276.6 million in 2024, then soared by 27,005.56% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $6.4 million for Q2 2025, and $3.2 million during Q1 2025.